KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio: 2018-2024

Historic Asset Utilization Ratio for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to 0.80.

  • Amneal Pharmaceuticals' Asset Utilization Ratio rose 8.69% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 8.69%. This contributed to the annual value of 0.80 for FY2024, which is 21.71% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.80 for FY2024, which was up 21.71% from 0.66 recorded in FY2023.
  • Amneal Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.80 for FY2024, and its period low was 0.52 during FY2020.
  • Its 3-year average for Asset Utilization Ratio is 0.68, with a median of 0.66 in 2023.
  • Data for Amneal Pharmaceuticals' Asset Utilization Ratio shows a peak YoY climbed of 28.05% (in 2020) over the last 5 years.
  • Over the past 5 years, Amneal Pharmaceuticals' Asset Utilization Ratio (Yearly) stood at 0.52 in 2020, then rose by 1.46% to 0.53 in 2021, then increased by 8.49% to 0.57 in 2022, then grew by 15.14% to 0.66 in 2023, then rose by 21.71% to 0.80 in 2024.